论文信息 - KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor - 字舞流文

KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor

M. Provencio | A. Romero | E. Sánchez-Herrero | B. Sierra-Rodero | A. Cruz-Bermúdez | V. Calvo | E. A. Uribelarrea | R. Serna-Blasco | S. Sanz-Moreno | A. Rodríguez-Festa | E. García-Veros | M. Casarrubios | R. Laza-Briviesca | X. Mielgo-Rubio | A. Sanchez-Hernandez